Upsized and oversubscribed Series B financing brings healthcare and science focused venture capital Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications OXFORD, England–( BUSINESS WIRE)–Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of…

Source

Previous articleatai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
Next articlePsychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin A